We studied global and splanchnic haemodynamics in patients with septic shock, while reducing norepinephrine doses by progressive fluid loading administration. Ten patients (six female, four male, aged 39-86 yr, mean 61 yr) were assessed using a transpulmonary thermo-dye dilution technique to measure cardiac output, intrathoracic blood volume and total blood volume. Splanchnic blood flow was measured by the steady state indocyanine green technique using a hepatic venous catheter. Gastric mucosal blood flow was estimated by regional carbon dioxide tension (PR CO2 ). Hydroxyethylstarch was infused in two stages while maintaining mean arterial pressure, allowing a reduction in norepinephrine dose from 0.54 to 0.33 to 0.21 µg kg -1 min -1 . Mean (SD) heart rate significantly decreased, from 104 (13) to 94 (15) beats min -1 . Total blood volume index (mean (SD)) increased from 2650 (638) to 3655 (885) ml m -2 , intrathoracic blood volume index from 888 (204) to 1050 (248) ml m -2 and cardiac index from 3.6 (1.0) to 4.0 (0.9) litres min -1 m -2 . Splanchnic blood flow did not change significantlyeither absolute (from 0.81 to 0.98 litres min -1 m -2 ) or fractional (from 22.3% to 23.9%). Gastric mucosal (PR CO2 ) increased from 7.5 (2.5) to 9.0 (2.8) kPa. The PCO 2 gap, i.e. the difference between regional and end-tidal PCO 2 , increased from 3.1 (2.5) to 4.0 (2.9) kPa. Marked individual variation in responses suggests that norepinephrine dose reduction by fluid loading in patients with stabilized septic shock does not necessarily increase global or splanchnic blood flow.
Accepted for publication: January 7, 2000 Vasopressors are often needed to maintain adequate perfu-decrease in norepinephrine infusion (maintaining mean arterial pressure constant) could improve global and regional sion pressure in patients with septic shock. Norepinephrine blood flow and oxygenation in patients with successfully increases urine output in patients with septic shock and stabilized septic shock. hypotension. 1-3 It may improve splanchnic perfusion, when compared with epinephrine or dopamine. 4 5 However, it is widely accepted that volume status should be restored Patients and methods before using vasopressors, and fluid resuscitation of patients After approval by our institutional review board and with sepsis or septic shock is often guided by the principle informed consent from each patient's next-of-kin, we of minimizing the need for vasopressor therapy.
prospectively studied 10 patients (six female, four male, In general, sufficient fluids should be given to aged 39-86 yr (mean 61 yr)) who had abdominal sepsis maximize cardiac output. 6 However, assessment of a and septic shock according to the criteria of the ACCPpatient's volume status and cardiac preload is difficult. Using SCCM consensus conference. 7 The mean (SD) simplified information obtained by pulmonary artery catheterization to acute physiology (SAPS II) score 8 was 48 (9) and sepsisassess cardiac preload may not improve outcome. Other related organ failure assessment (SOFA) score 9 was 13 clinical features may be useful to guide fluid therapy. If (1). Patients were sedated according to body weight with norepinephrine requirements can be reduced by fluid load-fentanyl 0.4-0.6 mg h -1 , dehydroperidol 5.0-7.5 mg h -1 ing, then a pre-existing fluid deficit may have been present. and midazolam ഛ15 mg h -1 . In each patient, doses of sedatives remained unchanged during the study period. We therefore investigated whether fluid loading and a All patients were mechanically ventilated in a pressure-and liver venous blood pressures, we recorded central venous pressure, ITBVI, TBVI, and transpulmonary thermocontrolled mode (Evita 4; Draeger Werke, Luebeck, Germany) and PEEP (10-15 mbar) was adjusted indivi-dilution cardiac output. Gastric mucosal (PR CO2 ) was measured with a 16 French tonometric probe (Trip NGS catheter; dually according to blood gas monitoring. Airway pressures remained unchanged throughout the study. In Tonometrics Division, Helsinki, Finland). The patients did not receive enteral nutrition or antacids during the study this study, dobutamine doses were kept constant (mean 3.75 µg kg -1 min -1 ) and only the norepinephrine was period. Because of Boerhaave syndrome in patient 6 and erosive gastritis in patient 8, (PR CO2 ) was not obtained for reduced to keep mean arterial pressure constant. No other vasopressors were used. those two patients. Systemic oxygen delivery (DO 2 I) was calculated from the equation For haemodynamic monitoring, a femoral artery sheath was inserted in each patient. A 4 French flexible catheter DO 2 I ϭ (haemoglobin concentrationϫoxygen saturationϫ with an integrated thermistor and fibre optic (Pulsiocath 4F, 1.36 ϩ oxygen partial pressureϫ0.0031)ϫCI PV 2024L; Pulsion Medical Systems, Munich, Germany) was advanced through the sheath into the abdominal aorta. Systemic oxygen consumption (VO 2 I) was measured using Intrathoracic blood volume (ITBV) and total blood volume a metabolic cart (Deltatrac II; Datex-Engström, Helsinki, (TBV) were calculated using a computer system (COLD-Finland). No calorimetric data could be obtained for patient Z021; Pulsion Medical Systems, Munich, FRG). In this 1 because of technical problems. method, ITBV is calculated by the mean transit time
Study plan
approach and TBV by back extrapolation of the aortic indocyanine green (ICG) dilution curve. 10 Each bolus injec-Following a first ICG bolus of 30 mg, a continuous ICG tion used cooled (4-6°C) ICG (Pulsion Medical Systems) infusion was started (37.5 mg h -1 ). After 20, 25 and 30 min 2 mg ml -1 (15 ml per bolus). To verify results, each bolus of infusion, arterial and hepatic venous blood samples of ICG was followed by two injections of cooled saline. were taken to confirm steady-state conditions of ICG All bolus injections were manual and not related to the concentrations. After 30 min of ICG infusion, baseline ventilatory cycle.
haemodynamic measurements were made. Then fluid was A hepatic venous catheter (7.5 French five-lumen pulmon-given in two steps by using 200 kDa hydroxyethylstarch ary artery catheter, Edwards Swan Ganz, CCO/SvO 2 , Model 10% (HAES 10 steril; Fresenius AG, Bad Homburg, 744H 7.5 F; Baxter Healthcare Corporation, Irvine, CA, Germany). Haematocrit was kept constant throughout the USA) was inserted from the right internal jugular vein study by transfusion of packed red blood cells. The under fluoroscopic control for continuous measurement of norepinephrine dose was adjusted to keep mean arterial oxygen saturation (ShvO 2 ). The correct position of the pressure constant. The whole study lasted 4 h, and haemocatheter was verified before and after each study. dynamic measurements were obtained at baseline and after Splanchnic blood flow was evaluated by the steady-state 2 and 4 h. ICG (Pulsion Medical Systems) dye technique. Plasma ICG concentrations were assessed spectrophotometrically at a Data analysis wavelength of 805 nm. Hepatic ICG extraction (E) was All results are expressed as mean (SD). For betweencalculated from the equation individual comparison, values were normalized (indexed) by body surface area derived according to DuBois. E(%) ϭ (arterial -venous ICG concentration)/arterial ICG Statistical analysis was performed using an analysis of concentration variance for repeated measurements and all-pairwise and hepatic blood flow (Q SPL ) from the equation 11 multiple comparison procedure (Student-Newman-Keuls method, SigmaStat). PϽ0.05 was taken as statistically
Arterial and hepatic venous blood gas samples were
Results
immediately analysed for measurement of oxygen and carbon dioxide tensions, pH, haematocrit, haemoglobin Global haemodynamic and regional splanchnic oxygenation variables are summarized in Tables 1 and 2 . In the first concentration, haemoglobin saturation, lactate and glucose levels (Radiometer System 625, Copenhagen, Denmark). and second steps, respectively, 765 (233) and 705 (222) ml of hydroxyethylstarch were infused. Both fluid administraHepatic lactate and glucose exchange were calculated as the product of splanchnic blood flow multiplied by the tions caused a significant increase in total blood volume and it was possible to reduce norepinephrine doses withdifference between the liver venous and arterial concentrations.
out altering mean arterial pressure. To maintain a stable haematocrit, each patient received 2 units of packed red For the measurement of venous pressures, patients were in the horizontal position and not disconnected from the blood cells (each 300 (30) ml) during the 4 h period. Heart rate decreased significantly from 104 (13) to 94 (15) beats respirator. As well as continuous measurement of arterial 
Discussion
during the study period. TBVI increased from 2650 (638) to 3655 (885) ml m -2 . Although mean splanchnic blood These data show that, in patients with haemodynamically stabilized septic shock, reduction in norepinephrine infusion tended to be higher after fluid loading, neither absolute splanchnic blood flow (which changed from 0.81 to 0.98 litre after fluid loading did not increase splanchnic blood flow.
Intrathoracic blood volume increased; this is a more appromin -1 m -2 ) nor fractional splanchnic blood flow (from 22.3% to 23.9%) changed significantly at either stage. The priate measure than the cardiac filling pressures to assess cardiac preload in the critically ill. [12] [13] [14] We conclude that individual data showed that, in some patients, cardiac index and absolute splanchnic blood flow even decreased the fluid increased cardiac preload in our patients. As the norepinephrine dose could be reduced in every patient while (Fig. 1) . The difference between regional and end-tidal P CO2 (P CO2 gap) increased from 3.1 (2.5) to 3.3 (2.9) and 4.0 mean arterial pressure remained constant, pre-existing fluid deficit was likely. Nevertheless, marked individual differ-(2.9) kPa. ences in global and splanchnic haemodynamics were found load in some of our patients. Fluid overload may have contributed, since total blood volume increased from normal after fluid was given. Fluid administration and vasopressor dose reduction did not always increase cardiac index. Some to supranormal values during the study period. Furthermore, central venous and hepatic venous pressures increased to patients had increased splanchnic perfusion with increased cardiac index, but other patients did not. Thus, fluid loading very high levels, which may impair splanchnic blood flow by the reduced perfusion pressure gradient. Animal studies 18 and a reduction in vasopressor support with a constant mean arterial pressure are not always associated with showed that sinusoidal pressure in the liver increases considerably with increasing central venous pressure and improved global or regional perfusion. Furthermore, regional carbon dioxide tension and carbon dioxide gap that the portion of the central venous pressure transmitted to the sinusoids increases exponentially. Thus, impaired increased significantly during fluid loading, which may suggest a reduction in splanchnic blood flow or could be hepatic venous drainage may have reduced gastric and splanchnic blood flow in some patients. Finally, individual interpreted as a consecutive 'washout phenomenon'.
Norepinephrine increases splanchnic vascular resistance differences in central venous pressure and splanchnic perfusion pressure may explain the individual variations in and thus decreases splanchnic blood flow in animals and humans in non-septic conditions. 15 16 Bersten and col-splanchnic blood flow. A major limitation of our study is the lack of a control group, which would have allowed leagues 16 did not find a redistribution of blood flow with norepinephrine infusion, away from the kidneys, liver and comparison of these data on splanchnic blood flow with septic shock patients who remained fluid depleted. pancreas, in septic animals. Norepinephrine can improve splanchnic oxygenation by increasing mean arterial pressure Septic patients respond in different ways to vasoactive substances. 19 20 In these studies, the effects of norepiin septic patients. 4 Patients receiving norepinephrine had an increase in gastric mucosal pH (pH i ), indicating an nephrine and low-dose dopamine on splanchnic blood flow were unpredictable between different individuals. Our increase in microcirculatory perfusion, whereas dopamine caused a decrease in pH i . Thus, norepinephrine seems to results support these observations: septic patients do not respond uniformly to therapeutic interventions. have some potential positive effects on splanchnic blood flow in patients with sepsis. However, mean arterial pressure Conclusion was constant in this study, so perfusion pressure alone does not appear to cause these benefits.
A decrease in norepinephrine dose following fluid adminisNevertheless, these results should not be interpreted as tration cannot be interpreted as a sign of improved global showing that fluid resuscitation, which is still one of the or regional blood flow. Further studies are needed to most important supportive treatments in sepsis, is less understand the differing response of splanchnic perfusion beneficial than norepinephrine therapy. In our patients, mean among patients, and to identify the most appropriate dose splanchnic blood flow tended to be greater after fluid of vasopressor for the individual patient. loading. According to recent recommendations, optimization of cardiac output is a major goal in treatment of patients References with sepsis and vasopressors should only be used after 
